Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation.

about

Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation.

Item

http://www.wikidata.org/entity/Q42286343

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@en

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@nl

type

Item

label

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@en

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@nl

prefLabel

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@en

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@nl

P1476

Once-daily rivaroxaban for lon ...... ents with atrial fibrillation.

@en

P2093

Sotiris Antoniou

http://www.w3.org/2001/XMLSchema#string

Walid Amara

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

A systematic review of the associations between dose regimens and medication compliance.

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

P304

D7-D15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/SUV061

http://www.w3.org/2001/XMLSchema#string

P433

Suppl D

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301627483

http://www.w3.org/2001/XMLSchema#string

P698

28533707

http://www.w3.org/2001/XMLSchema#string

P932

5421203

http://www.w3.org/2001/XMLSchema#string